| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +5% |
| 3Y CAGR | +20% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -13% |
| 3Y CAGR | +53% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,352.40 +78.50 (3.45%) | 17,895.81 | 26.39 | 5.31 | ||
PfizerPFIZER | ₹3,709.80 +22.60 (0.61%) | 16,975.61 | 23.09 | 4.04 | ||
Natco PharmaNATCOPHARM | ₹794.55 +4.35 (0.55%) | 15,576.72 | 13.61 | 1.48 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,073.00 +21.50 (0.36%) | 15,182.75 | 89.51 | 17.4 |